Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

Impact of a standard versus collective-efficacy enhanced intervention to increase physical activity among mothers.

Dlugonski D, Das BM, Martin TR.

Psychol Health. 2019 Jun 17:1-15. doi: 10.1080/08870446.2019.1626397. [Epub ahead of print]

PMID:
31204499
2.

Healthcare professionals' use of augmentative and alternative communication in an intensive care unit: A survey study.

Jansson S, Martin TRS, Johnson E, Nilsson S.

Intensive Crit Care Nurs. 2019 Apr 17. pii: S0964-3397(18)30365-3. doi: 10.1016/j.iccn.2019.04.002. [Epub ahead of print]

PMID:
31005487
3.

A Framework for Contracted Health IT Performance Assessments.

Martin TR, Gasoyan H, Wierz DJ.

Hosp Top. 2019 Jan;97(1):15-22. doi: 10.1080/00185868.2018.1556371. Epub 2019 Jan 12.

PMID:
30636540
4.

Overview of Innate Lung Immunity and Inflammation.

Riches DWH, Martin TR.

Methods Mol Biol. 2018;1809:17-30. doi: 10.1007/978-1-4939-8570-8_2. Review.

PMID:
29987779
5.

Optimizing Stem Length To Improve Ligand Selectivity in a Structure-Switching Cocaine-Binding Aptamer.

Neves MAD, Shoara AA, Reinstein O, Abbasi Borhani O, Martin TR, Johnson PE.

ACS Sens. 2017 Oct 27;2(10):1539-1545. doi: 10.1021/acssensors.7b00619. Epub 2017 Oct 2.

PMID:
28929744
6.

Development of a thermal-stable structure-switching cocaine-binding aptamer.

Shoara AA, Reinstein O, Borhani OA, Martin TR, Slavkovic S, Churcher ZR, Johnson PE.

Biochimie. 2018 Feb;145:137-144. doi: 10.1016/j.biochi.2017.08.010. Epub 2017 Aug 21.

PMID:
28838608
7.

Collective Efficacy, Physical Activity, and Health Outcomes Among Mothers.

Dlugonski D, Das BM, Martin TR, Palmer A.

Fam Community Health. 2017 Oct/Dec;40(4):316-323. doi: 10.1097/FCH.0000000000000162.

PMID:
28820785
8.

Asthma research in Europe: a transformative agenda for innovation and competitiveness.

Papadopoulos NG, Androutsopoulou A, Akdis C, Dahlén SE, Djukanovic R, Edwards J, Garcia-Marcos L, Johnston SL, Kupczyk M, Martin TR, Myles D, Palkonen S, Powell P, Riley J, Walker S.

Eur Respir J. 2017 May 1;49(5). pii: 1602294. doi: 10.1183/13993003.02294-2016. Print 2017 May. No abstract available.

9.

Synthesis of Ligand-free CdS Nanoparticles within a Sulfur Copolymer Matrix.

Martin TR, Mazzio KA, Hillhouse HW, Luscombe CK.

J Vis Exp. 2016 May 1;(111). doi: 10.3791/54047.

10.

COPD disease severity and innate immune response to pathogen-associated molecular patterns.

Fan VS, Gharib SA, Martin TR, Wurfel MM.

Int J Chron Obstruct Pulmon Dis. 2016 Mar 4;11:467-77. doi: 10.2147/COPD.S94410. eCollection 2016.

11.

Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.

Miller BE, Tal-Singer R, Rennard SI, Furtwaengler A, Leidy N, Lowings M, Martin UJ, Martin TR, Merrill DD, Snyder J, Walsh J, Mannino DM.

Am J Respir Crit Care Med. 2016 Mar 15;193(6):607-13. doi: 10.1164/rccm.201509-1722PP. Review.

PMID:
26745765
12.

High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion.

Chung DW, Chen J, Ling M, Fu X, Blevins T, Parsons S, Le J, Harris J, Martin TR, Konkle BA, Zheng Y, López JA.

Blood. 2016 Feb 4;127(5):637-45. doi: 10.1182/blood-2014-09-599530. Epub 2015 Nov 9.

13.

Sulfur copolymer for the direct synthesis of ligand-free CdS nanoparticles.

Martin TR, Mazzio KA, Hillhouse HW, Luscombe CK.

Chem Commun (Camb). 2015 Jun 30;51(56):11244-7. doi: 10.1039/c5cc03587b.

PMID:
26077505
14.

Drug development for airway diseases: looking forward.

Holgate S, Agusti A, Strieter RM, Anderson GP, Fogel R, Bel E, Martin TR, Reiss TF.

Nat Rev Drug Discov. 2015 Jun;14(6):367-8. doi: 10.1038/nrd4645. Epub 2015 May 22.

PMID:
26000726
15.

Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures.

Lieberman TD, Flett KB, Yelin I, Martin TR, McAdam AJ, Priebe GP, Kishony R.

Nat Genet. 2014 Jan;46(1):82-7. doi: 10.1038/ng.2848. Epub 2013 Dec 8.

16.

Mechanisms of acute respiratory distress syndrome in children and adults: a review and suggestions for future research.

Smith LS, Zimmerman JJ, Martin TR.

Pediatr Crit Care Med. 2013 Jul;14(6):631-43. doi: 10.1097/PCC.0b013e318291753f. Review.

PMID:
23823199
17.

The Fas/FasL pathway impairs the alveolar fluid clearance in mouse lungs.

Herrero R, Tanino M, Smith LS, Kajikawa O, Wong VA, Mongovin S, Matute-Bello G, Martin TR.

Am J Physiol Lung Cell Mol Physiol. 2013 Sep;305(5):L377-88. doi: 10.1152/ajplung.00271.2012. Epub 2013 Jun 28.

18.

Time for a relevant randomized controlled trial of vena cava filters.

Martin TR, Christmas AB, Gibeault LA, Heniford BT, Sing RF.

J Am Osteopath Assoc. 2013 Jan;113(1):11-2. No abstract available.

PMID:
23329800
19.

Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity.

Hunter RC, Klepac-Ceraj V, Lorenzi MM, Grotzinger H, Martin TR, Newman DK.

Am J Respir Cell Mol Biol. 2012 Dec;47(6):738-45. doi: 10.1165/rcmb.2012-0088OC. Epub 2012 Aug 3. Retraction in: Am J Respir Cell Mol Biol. 2019 Jan;60(1):134.

PMID:
22865623
20.

Complete genome sequences of Mycoplasma leachii strain PG50T and the pathogenic Mycoplasma mycoides subsp. mycoides small colony biotype strain Gladysdale.

Wise KS, Calcutt MJ, Foecking MF, Madupu R, DeBoy RT, Röske K, Hvinden ML, Martin TR, Durkin AS, Glass JI, Methé BA.

J Bacteriol. 2012 Aug;194(16):4448-9. doi: 10.1128/JB.00761-12.

21.

Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection.

Skurnik D, Davis MR Jr, Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, Traficante DC, Walsh RL, Maira-Litràn T, Cassidy SK, Hermos CR, Martin TR, Thakkallapalli EL, Vargas SO, McAdam AJ, Lieberman TD, Kishony R, Lipuma JJ, Pier GB, Goldberg JB, Priebe GP.

J Infect Dis. 2012 Jun;205(11):1709-18. doi: 10.1093/infdis/jis254. Epub 2012 Mar 23.

22.

Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide.

Tanino Y, Chang MY, Wang X, Gill SE, Skerrett S, McGuire JK, Sato S, Nikaido T, Kojima T, Munakata M, Mongovin S, Parks WC, Martin TR, Wight TN, Frevert CW.

Am J Respir Cell Mol Biol. 2012 Aug;47(2):196-202. doi: 10.1165/rcmb.2011-0294OC. Epub 2012 Mar 15.

23.

Into the eye of the cytokine storm.

Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG.

Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32. doi: 10.1128/MMBR.05015-11. Review.

24.

The Parker B. Francis Fellowship Program: analysis of 31 years of career development support.

Martin TR, Snapp DL, Tomita DM.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):479-85. doi: 10.1164/rccm.201108-1390PP. Epub 2011 Nov 17.

PMID:
22095548
25.

Lysostaphin-coated mesh prevents staphylococcal infection and significantly improves survival in a contaminated surgical field.

Belyansky I, Tsirline VB, Montero PN, Satishkumar R, Martin TR, Lincourt AE, Shipp JI, Vertegel A, Heniford BT.

Am Surg. 2011 Aug;77(8):1025-31.

PMID:
21944518
26.

Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins.

Bera MM, Lu B, Martin TR, Cui S, Rhein LM, Gerard C, Gerard NP.

J Immunol. 2011 Oct 15;187(8):4245-55. doi: 10.4049/jimmunol.1101789. Epub 2011 Sep 14.

27.

Role of the Fas/FasL system in a model of RSV infection in mechanically ventilated mice.

van den Berg E, van Woensel JB, Bos AP, Bem RA, Altemeier WA, Gill SE, Martin TR, Matute-Bello G.

Am J Physiol Lung Cell Mol Physiol. 2011 Oct;301(4):L451-60. doi: 10.1152/ajplung.00368.2010. Epub 2011 Jul 8.

28.

Experimental models and emerging hypotheses for acute lung injury.

Martin TR, Matute-Bello G.

Crit Care Clin. 2011 Jul;27(3):735-52. doi: 10.1016/j.ccc.2011.05.013. Review.

29.

The addition of lysostaphin dramatically improves survival, protects porcine biomesh from infection, and improves graft tensile shear strength.

Belyansky I, Tsirline VB, Martin TR, Klima DA, Heath J, Lincourt AE, Satishkumar R, Vertegel A, Heniford BT.

J Surg Res. 2011 Dec;171(2):409-15. doi: 10.1016/j.jss.2011.04.014. Epub 2011 May 5.

PMID:
21696759
30.

Perceptions of student-observers in the operating room.

Palilonis MA, Martin TR, Jacobs D, Gersin KS, Iannitti DA, McKillop IH, Heniford BT.

J Surg Res. 2011 Oct;170(2):195-201. doi: 10.1016/j.jss.2011.03.046. Epub 2011 Apr 16.

PMID:
21683372
31.

Poor resident-attending intraoperative communication may compromise patient safety.

Belyansky I, Martin TR, Prabhu AS, Tsirline VB, Howley LD, Phillips R, Sindram D, Heniford BT, Stefanidis D.

J Surg Res. 2011 Dec;171(2):386-94. doi: 10.1016/j.jss.2011.04.011. Epub 2011 May 6.

PMID:
21601875
32.

Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury.

Lipke AB, Matute-Bello G, Herrero R, Wong VA, Mongovin SM, Martin TR.

Am J Physiol Lung Cell Mol Physiol. 2011 Jul;301(1):L60-70. doi: 10.1152/ajplung.00314.2010. Epub 2011 Apr 22.

33.

A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury.

Stapleton RD, Martin TR, Weiss NS, Crowley JJ, Gundel SJ, Nathens AB, Akhtar SR, Ruzinski JT, Caldwell E, Curtis JR, Heyland DK, Watkins TR, Parsons PE, Martin JM, Wurfel MM, Hallstrand TS, Sims KA, Neff MJ.

Crit Care Med. 2011 Jul;39(7):1655-62. doi: 10.1097/CCM.0b013e318218669d.

34.

The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region.

Herrero R, Kajikawa O, Matute-Bello G, Wang Y, Hagimoto N, Mongovin S, Wong V, Park DR, Brot N, Heinecke JW, Rosen H, Goodman RB, Fu X, Martin TR.

J Clin Invest. 2011 Mar;121(3):1174-90. doi: 10.1172/JCI43004.

35.

Genetic variation in the FAS gene and associations with acute lung injury.

Glavan BJ, Holden TD, Goss CH, Black RA, Neff MJ, Nathens AB, Martin TR, Wurfel MM; ARDSnet Investigators.

Am J Respir Crit Care Med. 2011 Feb 1;183(3):356-63. doi: 10.1164/rccm.201003-0351OC. Epub 2010 Sep 2.

36.

Clinically useful spirometry in preschool-aged children: evaluation of the 2007 American Thoracic Society Guidelines.

Gaffin JM, Shotola NL, Martin TR, Phipatanakul W.

J Asthma. 2010 Sep;47(7):762-7. doi: 10.3109/02770903.2010.485664.

37.

Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury.

Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L, Mai TT, Marbach H, Braughton KR, Whitney AR, Gardner DJ, Fan X, Tseng CW, Liu GY, Badiou C, Etienne J, Lina G, Matthay MA, DeLeo FR, Chambers HF.

Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5587-92. doi: 10.1073/pnas.0912403107. Epub 2010 Mar 15.

38.

Febrile-range hyperthermia augments lipopolysaccharide-induced lung injury by a mechanism of enhanced alveolar epithelial apoptosis.

Lipke AB, Matute-Bello G, Herrero R, Kurahashi K, Wong VA, Mongovin SM, Martin TR.

J Immunol. 2010 Apr 1;184(7):3801-13. doi: 10.4049/jimmunol.0903191. Epub 2010 Mar 3.

39.

Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

Klepac-Ceraj V, Lemon KP, Martin TR, Allgaier M, Kembel SW, Knapp AA, Lory S, Brodie EL, Lynch SV, Bohannan BJ, Green JL, Maurer BA, Kolter R.

Environ Microbiol. 2010 May;12(5):1293-303. doi: 10.1111/j.1462-2920.2010.02173.x. Epub 2010 Feb 23.

PMID:
20192960
40.

Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.

Tanino Y, Coombe DR, Gill SE, Kett WC, Kajikawa O, Proudfoot AE, Wells TN, Parks WC, Wight TN, Martin TR, Frevert CW.

J Immunol. 2010 Mar 1;184(5):2677-85. doi: 10.4049/jimmunol.0903274. Epub 2010 Feb 1.

41.

Effects of age on the synergistic interactions between lipopolysaccharide and mechanical ventilation in mice.

Smith LS, Gharib SA, Frevert CW, Martin TR.

Am J Respir Cell Mol Biol. 2010 Oct;43(4):475-86. doi: 10.1165/rcmb.2009-0039OC. Epub 2009 Nov 9.

42.

Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury.

Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA; NHLBI ARDS Clinical Trials Network.

Chest. 2010 Feb;137(2):288-96. doi: 10.1378/chest.09-1484. Epub 2009 Oct 26.

43.

Comparison of two non-bronchoscopic methods for evaluating inflammation in patients with acute hypoxaemic respiratory failure.

Colucci G, Domenighetti G, Della Bruna R, Bonilla J, Limoni C, Matthay MA, Martin TR.

Crit Care. 2009;13(4):R134. doi: 10.1186/cc7995. Epub 2009 Aug 11.

44.

Depletion of phagocytes in the reticuloendothelial system causes increased inflammation and mortality in rabbits with Pseudomonas aeruginosa pneumonia.

Kurahashi K, Sawa T, Ota M, Kajikawa O, Hong K, Martin TR, Wiener-Kronish JP.

Am J Physiol Lung Cell Mol Physiol. 2009 Feb;296(2):L198-209. doi: 10.1152/ajplung.90472.2008. Epub 2008 Nov 21.

45.

Mechanical ventilation enhances lung inflammation and caspase activity in a model of mouse pneumovirus infection.

Bem RA, van Woensel JB, Bos AP, Koski A, Farnand AW, Domachowske JB, Rosenberg HF, Martin TR, Matute-Bello G.

Am J Physiol Lung Cell Mol Physiol. 2009 Jan;296(1):L46-56. doi: 10.1152/ajplung.00467.2007. Epub 2008 Nov 7.

46.

Role of proinflammatory activity contained in gastric juice from intensive care unit patients to induce lung injury in a rabbit aspiration model.

Brégeon F, Papazian L, Delpierre S, Kajikawa O, Payan MJ, Martin TR, Kipson N, Pugin J.

Crit Care Med. 2008 Dec;36(12):3205-12. doi: 10.1097/CCM.0b013e31818f0e20.

PMID:
18936704
47.

Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome.

Chang DW, Hayashi S, Gharib SA, Vaisar T, King ST, Tsuchiya M, Ruzinski JT, Park DR, Matute-Bello G, Wurfel MM, Bumgarner R, Heinecke JW, Martin TR.

Am J Respir Crit Care Med. 2008 Oct 1;178(7):701-9. doi: 10.1164/rccm.200712-1895OC. Epub 2008 Jul 24.

48.

Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis.

Wurfel MM, Gordon AC, Holden TD, Radella F, Strout J, Kajikawa O, Ruzinski JT, Rona G, Black RA, Stratton S, Jarvik GP, Hajjar AM, Nickerson DA, Rieder M, Sevransky J, Maloney JP, Moss M, Martin G, Shanholtz C, Garcia JG, Gao L, Brower R, Barnes KC, Walley KR, Russell JA, Martin TR.

Am J Respir Crit Care Med. 2008 Oct 1;178(7):710-20. doi: 10.1164/rccm.200803-462OC. Epub 2008 Jul 17.

49.

Animal models of acute lung injury.

Matute-Bello G, Frevert CW, Martin TR.

Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L379-99. doi: 10.1152/ajplung.00010.2008. Epub 2008 Jul 11. Review.

50.

Depletion of resident alveolar macrophages does not prevent Fas-mediated lung injury in mice.

Bem RA, Farnand AW, Wong V, Koski A, Rosenfeld ME, van Rooijen N, Frevert CW, Martin TR, Matute-Bello G.

Am J Physiol Lung Cell Mol Physiol. 2008 Aug;295(2):L314-25. doi: 10.1152/ajplung.00210.2007. Epub 2008 Jun 13.

Supplemental Content

Loading ...
Support Center